ASRS 2020: Alcon showcases latest retina innovations, data
ASRS 2020: Josh Anderson speaks on the highlights from Alcon, including new data on the performance benefits of the Hypervit dual blade 20,000 cpm probe and the launch of the NGENUITY 1.4 upgrade.
Clinical Trials in the COVID-19 Era
Telemedicine
Artificial Intelligence (AI) and Retina
Coming Down the Pike
Treatment Burden
Improved Durability
Treating the Whole Patient: When to Switch (and Why)
Real-World Experiences and Clinical Trials: Why Outcomes Differ
Treatment Strategies During a Pandemic
The Advent of the Anti-Vascular Endothelial Growth Factor (VEGF) Treatment Regimen
Intro
ASRS 2019 Street Team: Chuck Hess
